- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0048939

About Cellgen Biopharma Private Limited
Data last updated:
Cellgen Biopharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 17 March 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21001DL2023PTC411163.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Raghvendra Singh Kushwah and Akhil Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No 110 – 111 1st Floor, Rishabh Ipex Mall Patparganj, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.12 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹9.39 Lakh (net margin 2.3%) and EBITDA of ₹15.36 Lakh (EBITDA margin 3.7%).
As per MCA filings, the company has open charges of ₹62.5 Lakh on record.
Cellgen Biopharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0048939). For more details, the company can be reached via its website cellgenbiopharma.com.
Company details
Recognitions & Rankings of Cellgen Biopharma
Contact details
Cellgen Biopharma Private Limited's registered office is in New Delhi, Delhi.
- Social Media
- Registered AddressOffice No 110 – 111 1st Floor, Rishabh Ipex Mall Patparganj, New Delhi, Delhi, India – 110092
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cellgen Biopharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cellgen Biopharma Private Limited, buy the company report.
Financials of Cellgen Biopharma Private Limited
FY 2025 filings availableCellgen Biopharma Private Limited reported revenue of ₹4.12 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 31% in the latest year. EBITDA rose 25% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹15.36 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹9.39 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.7% | ||
| Net Profit Margin | 2.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Cellgen Biopharma Private Limited, buy the company report.
Board of directors of Cellgen Biopharma Private Limited
Cellgen Biopharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raghvendra Singh Kushwah | Director | 17 Mar 2023 | 3 Years 7 Months | Current |
| Akhil Gupta | Director | 17 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Cellgen Biopharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Biopharma, Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nadine Healthcare Private Limited | ₹4.14 Cr (FY 2025) | 3.0% | Kanpur, Uttar Pradesh, India | |||
| Vivrthi Labs Private Limited | ₹4.14 Cr (FY 2024) | -6.0% | Hyderabad, Telangana, India | |||
| Rus-Med Exports Private Limited | ₹4.13 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India | |||
| Cellgen Biopharma Private Limitedthis company | ₹4.12 Cr (FY 2025) | ₹9.39 Lakh | 2.3% | 31.0% | New Delhi, Delhi, India | |
| MSR Pharmaceuticals Private Limited | ₹4.11 Cr (FY 2025) | -10.0% | Patna, Bihar, India |
To see the full peer comparison of Cellgen Biopharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Feb 2025 | 101097053 | Hdfc Bank Limited | ₹62.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cellgen Biopharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cellgen Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cellgen Biopharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cellgen Biopharma Private Limited has 3 board changes on record since 2023: 2 appointments and 1 cessation. The latest: Anshita Garg ceased to be Director on 01 Dec 2024.
Frequently asked questions
Cellgen Biopharma is an active private limited company based in New Delhi, Delhi, India. The company works in paper and paper products, within the paper industry. It was incorporated on 17 March 2023 (3+ years old) and is registered under CIN U21001DL2023PTC411163.
Cellgen Biopharma has 2 current directors:
- Raghvendra Singh Kushwah - Director
- Akhil Gupta - Director
The latest financial statements of Cellgen Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Cellgen Biopharma is U21001DL2023PTC411163. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cellgen Biopharma was incorporated on 17 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Cellgen Biopharma by revenue are Nadine Healthcare Private Limited, Vivrthi Labs Private Limited, Rus-Med Exports Private Limited, MSR Pharmaceuticals Private Limited, all in the Pharma industry (Biopharma, Formulations), with the same principal business activity (wholesale trading).
Anshita Garg ceased to be Director on 01 Dec 2024. Akhil Gupta was appointed as Director on 17 Mar 2023. Raghvendra Singh Kushwah was appointed as Director on 17 Mar 2023.
Yes, Cellgen Biopharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0048939).
Cellgen Biopharma can be reached through the website cellgenbiopharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Cellgen Biopharma is at Office No 110 – 111 1st Floor, Rishabh Ipex Mall Patparganj, New Delhi, Delhi, India – 110092.
Cellgen Biopharma operates in the paper industry, in the paper and paper products segment.

